OUR NEWS & EVENTS

EpiEndo is very proud to be among 75 promising start-ups and SMEs to be selected by the European Innovation Council (EIC) to receive a grant

EpiEndo’s Founder, Fridrik Runar Gardarsson and Finnur Fridrik Einarsson (COO) will represent EpiEndo at the RESI conference in Boston on...

EpiEndo successfully closed our 4th seed round of 2 million Euros.

EpiEndo’s CEO, Fredrik Lehmann will represent EpiEndo at Nordic Life Science Days in Malmö on the 10th to 12th of September. He will also...

EpiEndo welcomes Jennifer Kricker, PhD to the team. Jennifer will take the role of Project Director. Jennifer has been involved with...

EpiEndo has been nominated for the Nordic Life Science Business Class and Deligates choice Awards EpiEndo is among 9 BioTechs that are...

EpiEndo is proud to introduce new external advisers to our Scientific Advisory Board (SAB) and welcome Professors Peter Barnes, Dave...

EpiEndo is pleased to announce that we have successfully closed a financing round of ISK 110 million (800.000 EUR). The financing was led...

EpiEndo is pleased to welcome Fredrik Lehmann to our team as the new CEO of EpiEndo. Fredrik has a PhD in Medicinal Chemistry from the...

EpiEndo is pleased to welcome Fredrik Lehmann to our team as the new CEO of EpiEndo. EpiEndo Pharmaceuticals has signed a grant agreement...

The following were appointed to the board of EpiEndo Pharmaceuticals at the Annual General Meeting on 17 March 2017. Professor Clive Page...

EpiEndo Pharmaceuticals are proud to announce that we have been granted a Horizon 2020 grant from the European Union (EU) for the...

EpiEndo Pharmaceuticals is proud to announce that we have received a 3 year grant from the Technology Development Fund, which is managed...

EpiEndo Pharmaceuticals are proud to announce our new partnership with Recipharm, a Swedish Contract Development and Manufacturing...

EpiEndo Pharmaceuticals has been granted a 2 year grant by RANNÍS - The Icelandic Centre for Research - for compound research and patent...